Key result
Bosentan reduces urine flow in intact rats, but renal denervation abolishes this response.
Why the study?
The role of renal endothelin-1 and its interaction with renal nerves in modulating kidney function and hypertension in spontaneously hypertensive rats was unclear.
Does bosentan or renal denervation alter kidney function and endothelin-1 expression in normotensive and spontaneously hypertensive rats?
Does bosentan or renal denervation alter kidney function and endothelin-1 expression in normotensive and spontaneously hypertensive rats?
Impaired renal endothelin-1 synthesis in spontaneously hypertensive rats may contribute to excessive sodium retention and the pathogenesis of hypertension by failing to counteract renal nerve activity.
Answers are grounded in this paper and cite their sources.
Does not inform clinical use of bosentan or denervation; leaves open endothelin-1's role in hypertensive kidney models.
Background and Methods: We investigated kidney function, renal endothelin-1 concentration, prepro-endothelin-1 mRNA as well as endothelin receptor A and B mRNA expression and receptor properties in normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) with intact renal nerves and 7 days after renal denervation. In addition, responses of renal function to the non-selective ETA/ETB receptor blocker bosentan (10 mg/kg i.v. bolus injection) were studied. Results: In SHR, renal papillary prepro-endothelin-1 mRNA expression, endothelin-1 tissue concentrations and endothelin receptor density were significantly lower than in normotensive rats. Renal denervation was associated with a decrease in papillary tissue prepro-endothelin-1 mRNA and in WKY rats also with a significant reduction in papillary endothelin-1 content without affecting ET receptor density. Bosentan did not alter renal blood flow or glomerular filtration rate but decreased urine flow rate in both intact normotensive and hypertensive rats, whereas it decreased urine sodium and potassium excretion only in intact WKY. Bosentan had no effects on renal function in renal denervated rats. Conclusion: Since renal papillary endothelin-1 appears to counteract the fluid and sodium retaining effects of renal nerve activity, an impaired renal endothelin-1 synthesis in SHR may contribute to excessive sodium retention and thus to the pathogenesis of hypertension in SHR.
No takes yet. Share an insight, caveat, or question.
Girchev et al. (2006) studied Hypertension. Bosentan and renal denervation vs. Intact renal nerves / normotensive rats was evaluated on Renal function and prepro-endothelin-1 mRNA expression. Bosentan decreased urine flow rate in intact normotensive and hypertensive rats, but had no effects on renal function in renal denervated rats.
Synapse has enriched 10 related papers. Consider them for comparative context: